Literature DB >> 12119239

Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease.

Gerald Reaven1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12119239     DOI： 10.1161/01.cir.0000019884.36724.d9

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  92 in total

1.  Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects.

Authors:  Martin Haluzík; Miloš Mráz; Štěpán Svačina
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

Review 2.  Diet and low-density lipoprotein particle size.

Authors:  Sophie Desroches; Benoît Lamarche
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 3.  Prediabetes and cardiovascular risk in hypertensive patients.

Authors:  Julian Segura; Cecilia Roldán; Jose A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 4.  Low-carbohydrate or low-fat diets for the metabolic syndrome?

Authors:  Michael L Dansinger; Ernst J Schaefer
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

Review 5.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 6.  Prediabetes mellitus and its links to atherosclerosis.

Authors:  Daniel Kramer; Annaswamy Raji; Jorge Plutzky
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

7.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

8.  Impaired coronary function in Wistar Ottawa Karlsburg W rats-a new model of the metabolic syndrome.

Authors:  Olaf Grisk; Tillmann Frauendorf; Torsten Schlüter; Ingrid Klöting; Beate Kuttler; Alexander Krebs; Jan Lüdemann; Rainer Rettig
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

9.  ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Authors:  C Noel Bairey Merz; Mark J Alberts; Gary J Balady; Christie M Ballantyne; Kathy Berra; Henry R Black; Roger S Blumenthal; Michael H Davidson; Sara B Fazio; Keith C Ferdinand; Lawrence J Fine; Vivian Fonseca; Barry A Franklin; Patrick E McBride; George A Mensah; Geno J Merli; Patrick T O'Gara; Paul D Thompson; James A Underberg
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

10.  Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.

Authors:  Naomi M Hamburg; Martin G Larson; Joseph A Vita; Ramachandran S Vasan; Michelle J Keyes; Michael E Widlansky; Caroline S Fox; Gary F Mitchell; Daniel Levy; James B Meigs; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2008-01-01       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.